Response by Kosiborod et al to Letters Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)"


Kosiborod, Mikhail, Cavender, Matthew A, Fu, Alex Z, Wilding, John P ORCID: 0000-0003-2839-8404, Khunti, Kamlesh, Holl, Reinhard W, Norhammar, Anna, Birkeland, Kare I, Jorgensen, Marit Eika, Thuresson, Marcus et al (show 4 more authors) (2018) Response by Kosiborod et al to Letters Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)". CIRCULATION, 137 (9). pp. 989-991.

[img] Text
Response to letters Circulation FINAL.docx - Author Accepted Manuscript
Download (17kB)
Item Type: Article
Uncontrolled Keywords: CVD-REAL Investigators and Study Group, Humans, Sodium, Glucose, Heart Failure, Canagliflozin, Sodium-Glucose Transporter 2 Inhibitors
Depositing User: Symplectic Admin
Date Deposited: 13 Apr 2018 10:18
Last Modified: 19 Jan 2023 06:36
DOI: 10.1161/CIRCULATIONAHA.117.031847
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3020123
Dimensions
Altmetric
CORE (COnnecting REpositories)